BIIB vs DHR
Biogen vs Danaher Corporation — AI-powered side-by-side comparison
VS
DHR
Danaher Corporation
63
Buy
| Metric | BIIB | DHR |
|---|
| AI Score |
67
|
63
|
| Price |
$208.02
|
$204.80
|
| P/E Ratio |
36.61×
|
36.24×
|
| ROE |
7.1%
|
6.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
67.7%
|
58.5%
|
| Debt / Equity |
0.44×
|
0.51×
|
| Dividend Yield |
0.0%
|
0.7%
|
| RSI (14) |
56.7
|
67.2
|
| Beta |
0.158
|
0.823
|
| Expected Upside |
+5.2%
|
+1.6%
|
AI Committee View
Current Innellis committee reasoning for BIIB versus DHR.
BIIB leads by 4 points.
BIIB scores 67/100 (Buy) versus DHR at 63/100 (Buy).
BIIB Committee View
80% agreement
5 analysts
The primary driver is news sentiment is positive (+0.42 across 47 articles, 14d). The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
DHR Committee View
80% agreement
5 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is p/e of 35.9 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 35.9 is moderate-to-rich — Value